Scientists Are Using Artificial Intelligence to Develop New Drugs Using Anonymous Data

Outer Places -- If there’s one thing drug companies hate more than unforeseen side effects, it’s sharing proprietary information about their drugs. Fortunately, a new study published in Science has shown that pharmaceutical companies can contribute to the ongoing process of discovering new drugs (and new uses for them) by training artificial intelligence on their data, which only the AIs are able to access. “This work is visionary,” says Jian Peng, a professor of computer science at Illinois. “I think (it) will lay the groundwork for the future of collaborations in biomedicine.”